Sean Laaman
Stock Analyst at Morgan Stanley
(4.80)
# 509
Out of 4,655 analysts
585
Total ratings
66.3%
Success rate
16.7%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintained: Buy | $1,200 → $1,230 | $987.84 | +24.51% | 12 | Aug 18, 2026 | |
| ALEC Alector | Rated: Sell | $2 | $2.05 | -2.44% | 6 | Aug 17, 2026 | |
| IRON Disc Medicine | Rated: Buy | $85 → $90 | $80.05 | +12.43% | 13 | Aug 17, 2026 | |
| CGEM Cullinan Therapeutics | Rated: Buy | $30 | $20.59 | +45.70% | 10 | Aug 17, 2026 | |
| RXRX Recursion Pharmaceuticals | Rated: Hold | $5.5 → $5.3 | $3.11 | +70.42% | 5 | Aug 17, 2026 | |
| ERAS Erasca | Rated: Hold | $21 | $18.28 | +14.88% | 8 | Aug 17, 2026 | |
| ABSI Absci | Rated: Hold | $10 | $9.24 | +8.23% | 9 | Aug 17, 2026 | |
| CGON CG Oncology | Rated: Buy | $93 | $77.11 | +20.61% | 14 | Aug 17, 2026 | |
| BBOT BridgeBio Oncology Therapeutics | Rated: Buy | $18 | $9.04 | +99.12% | 5 | Aug 17, 2026 | |
| CTNM Contineum Therapeutics | Rated: Hold | $16 → $18 | $14.53 | +23.88% | 9 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 | $11.25 | +86.75% | 7 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $10.47 | +205.64% | 2 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 | $15.69 | +40.22% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $280 → $283 | $248.36 | +13.95% | 17 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $196 → $182 | $154.49 | +17.81% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $17 | $17.40 | -2.30% | 6 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $97 | $79.89 | +21.42% | 7 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $26 → $27 | $29.01 | -6.93% | 13 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $242 → $251 | $216.27 | +16.06% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $119 → $124 | $66.64 | +86.07% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $105 | $103.00 | +1.94% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $36 → $40 | $24.35 | +64.27% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 → $43 | $35.05 | +22.68% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 | $52.32 | +1.30% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $395 → $405 | $362.51 | +11.72% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.95 | +11.86% | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $8.00 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.80 → $3.95 | $5.05 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $220.37 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.70 | $31.63 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310.00 | $134.60 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.60 → $31.65 | $22.81 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.38 → $24.14 | $35.00 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.83 → $27.77 | $42.19 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $276.00 → $256.00 | $131.25 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.30 | $0.46 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.15 → $7.35 | $7.44 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.45 → $1.65 | $0.70 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46.86 → $45.66 | $21.32 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.60 → $51.60 | $44.81 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.70 → $2.75 | $2.23 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.13 | n/a | 2 | Aug 24, 2021 |
argenx SE
Aug 18, 2026
Maintained: Buy
Price Target: $1,200 → $1,230
Current: $987.84
Upside: +24.51%
Alector
Aug 17, 2026
Rated: Sell
Price Target: $2
Current: $2.05
Upside: -2.44%
Disc Medicine
Aug 17, 2026
Rated: Buy
Price Target: $85 → $90
Current: $80.05
Upside: +12.43%
Cullinan Therapeutics
Aug 17, 2026
Rated: Buy
Price Target: $30
Current: $20.59
Upside: +45.70%
Recursion Pharmaceuticals
Aug 17, 2026
Rated: Hold
Price Target: $5.5 → $5.3
Current: $3.11
Upside: +70.42%
Erasca
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $18.28
Upside: +14.88%
Absci
Aug 17, 2026
Rated: Hold
Price Target: $10
Current: $9.24
Upside: +8.23%
CG Oncology
Aug 17, 2026
Rated: Buy
Price Target: $93
Current: $77.11
Upside: +20.61%
BridgeBio Oncology Therapeutics
Aug 17, 2026
Rated: Buy
Price Target: $18
Current: $9.04
Upside: +99.12%
Contineum Therapeutics
Aug 17, 2026
Rated: Hold
Price Target: $16 → $18
Current: $14.53
Upside: +23.88%
Aug 17, 2026
Rated: Hold
Price Target: $21
Current: $11.25
Upside: +86.75%
Aug 17, 2026
Rated: Buy
Price Target: $32
Current: $10.47
Upside: +205.64%
Aug 17, 2026
Rated: Buy
Price Target: $22
Current: $15.69
Upside: +40.22%
Aug 13, 2026
Rated: Buy
Price Target: $280 → $283
Current: $248.36
Upside: +13.95%
Aug 13, 2026
Rated: Hold
Price Target: $196 → $182
Current: $154.49
Upside: +17.81%
Aug 12, 2026
Rated: Hold
Price Target: $17
Current: $17.40
Upside: -2.30%
Aug 11, 2026
Reiterated: Buy
Price Target: $98 → $97
Current: $79.89
Upside: +21.42%
Aug 10, 2026
Rated: Hold
Price Target: $26 → $27
Current: $29.01
Upside: -6.93%
Aug 10, 2026
Maintained: Hold
Price Target: $242 → $251
Current: $216.27
Upside: +16.06%
Aug 7, 2026
Rated: Buy
Price Target: $119 → $124
Current: $66.64
Upside: +86.07%
Aug 7, 2026
Rated: Buy
Price Target: $93 → $105
Current: $103.00
Upside: +1.94%
Aug 7, 2026
Rated: Buy
Price Target: $36 → $40
Current: $24.35
Upside: +64.27%
Aug 7, 2026
Maintained: Hold
Price Target: $40 → $43
Current: $35.05
Upside: +22.68%
Aug 6, 2026
Maintained: Hold
Price Target: $53
Current: $52.32
Upside: +1.30%
Aug 6, 2026
Rated: Buy
Price Target: $395 → $405
Current: $362.51
Upside: +11.72%
Aug 28, 2025
Maintained: Buy
Price Target: $3.30
Current: $2.95
Upside: +11.86%
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $8.00
Upside: n/a
Feb 12, 2025
Maintained: Hold
Price Target: $3.80 → $3.95
Current: $5.05
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $220.37
Upside: n/a
Jun 24, 2024
Maintained: Buy
Price Target: $33.70
Current: $31.63
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $310.00
Current: $134.60
Upside: n/a
May 22, 2024
Maintained: Buy
Price Target: $33.60 → $31.65
Current: $22.81
Upside: n/a
Apr 9, 2024
Maintained: Hold
Price Target: $25.38 → $24.14
Current: $35.00
Upside: n/a
Mar 22, 2024
Maintained: Hold
Price Target: $25.83 → $27.77
Current: $42.19
Upside: n/a
Mar 21, 2024
Maintained: Sell
Price Target: $276.00 → $256.00
Current: $131.25
Upside: n/a
Feb 28, 2024
Maintained: Sell
Price Target: $1.30
Current: $0.46
Upside: n/a
Feb 27, 2024
Maintained: Hold
Price Target: $8.15 → $7.35
Current: $7.44
Upside: n/a
Feb 26, 2024
Maintained: Buy
Price Target: $1.45 → $1.65
Current: $0.70
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $46.86 → $45.66
Current: $21.32
Upside: n/a
Nov 28, 2023
Maintained: Hold
Price Target: $53.60 → $51.60
Current: $44.81
Upside: n/a
Aug 28, 2023
Maintained: Sell
Price Target: $2.70 → $2.75
Current: $2.23
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $16.13
Upside: n/a